| Elevated calprotectin and abnormal myeloid cell subsets discriminate severe from mild COVID-19 A Silvin, N Chapuis, G Dunsmore, AG Goubet, A Dubuisson, L Derosa, ... Cell 182 (6), 1401-1418. e18, 2020 | 800 | 2020 |
| Tumor-infiltrating lymphocytes and prognosis: a pooled individual patient analysis of early-stage triple-negative breast cancers S Loi, D Drubay, S Adams, G Pruneri, PA Francis, M Lacroix-Triki, ... Journal of clinical oncology 37 (7), 559-569, 2019 | 753 | 2019 |
| Intestinal Akkermansia muciniphila predicts clinical response to PD-1 blockade in patients with advanced non-small-cell lung cancer L Derosa, B Routy, AM Thomas, V Iebba, G Zalcman, S Friard, J Mazieres, ... Nature medicine 28 (2), 315-324, 2022 | 378 | 2022 |
| Ketogenic diet and ketone bodies enhance the anticancer effects of PD-1 blockade G Ferrere, MT Alou, P Liu, AG Goubet, M Fidelle, O Kepp, S Durand, ... JCI insight 6 (2), 2021 | 205 | 2021 |
| Federated learning for predicting histological response to neoadjuvant chemotherapy in triple-negative breast cancer J Ogier du Terrail, A Leopold, C Joly, C Béguier, M Andreux, C Maussion, ... Nature medicine 29 (1), 135-146, 2023 | 106 | 2023 |
| Mortality analyses in the updated French cohort of uranium miners (1946–2007) E Rage, S Caër-Lorho, D Drubay, S Ancelet, P Laroche, D Laurier International archives of occupational and environmental health 88, 717-730, 2015 | 86 | 2015 |
| A microbiota-modulated checkpoint directs immunosuppressive intestinal T cells into cancers M Fidelle, C Rauber, C Alves Costa Silva, AL Tian, I Lahmar, ... Science 380 (6649), eabo2296, 2023 | 82 | 2023 |
| Coronary stenosis risk analysis following Hodgkin lymphoma radiotherapy: a study based on patient specific artery segments dose calculation A Moignier, D Broggio, S Derreumaux, A Beaudré, T Girinsky, JF Paul, ... Radiotherapy and Oncology 117 (3), 467-472, 2015 | 70 | 2015 |
| Tumor infiltrating lymphocyte stratification of prognostic staging of early-stage triple negative breast cancer S Loi, R Salgado, S Adams, G Pruneri, PA Francis, M Lacroix-Triki, ... NPJ breast cancer 8 (1), 3, 2022 | 66 | 2022 |
| Pooled individual patient data analysis of tumor infiltrating lymphocytes (TILs) in primary triple negative breast cancer (TNBC) treated with anthracycline-based chemotherapy S Loi, D Drubay, S Adams, PA Francis, H Joensuu, MV Dieci, S Badve, ... San Antonio Breast Cancer Symposium, 2015 | 54 | 2015 |
| Mortality from circulatory system diseases among French uranium miners: a nested case-control study D Drubay, S Caer-Lorho, P Laroche, D Laurier, E Rage Radiation research 183 (5), 550-562, 2015 | 50 | 2015 |
| Prolonged SARS-CoV-2 RNA virus shedding and lymphopenia are hallmarks of COVID-19 in cancer patients with poor prognosis AG Goubet, A Dubuisson, A Geraud, FX Danlos, S Terrisse, CAC Silva, ... Cell Death & Differentiation 28 (12), 3297-3315, 2021 | 41 | 2021 |
| Kidney cancer mortality and ionizing radiation among French and German uranium miners D Drubay, S Ancelet, A Acker, M Kreuzer, D Laurier, E Rage Radiation and environmental biophysics 53, 505-513, 2014 | 32 | 2014 |
| A benchmark study of scoring methods for non-coding mutations D Drubay, D Gautheret, S Michiels Bioinformatics 34 (10), 1635-1641, 2018 | 29 | 2018 |
| Application of a risk-management framework for integration of stromal tumor-infiltrating lymphocytes in clinical trials J Hudeček, L Voorwerk, M van Seijen, I Nederlof, M de Maaker, ... NPJ Breast Cancer 6 (1), 15, 2020 | 28 | 2020 |
| A dual model for prioritizing cancer mutations in the non-coding genome based on germline and somatic events J Li, MA Poursat, D Drubay, A Motz, Z Saci, A Morillon, S Michiels, ... PLoS computational biology 11 (11), e1004583, 2015 | 27 | 2015 |
| Dynamics of circulating calprotectin accurately predict the outcome of moderate COVID-19 patients N Chapuis, N Ibrahimi, T Belmondo, C Goulvestre, AE Berger, ... EBioMedicine 80, 2022 | 18 | 2022 |
| Mining the coding and non-coding genome for cancer drivers J Li, D Drubay, S Michiels, D Gautheret Cancer letters 369 (2), 307-315, 2015 | 18 | 2015 |
| Immune infiltrate and tumor microenvironment transcriptional programs stratify pediatric osteosarcoma into prognostic groups at diagnosis A Marchais, ME Marques da Costa, B Job, R Abbas, D Drubay, ... Cancer research 82 (6), 974-985, 2022 | 17 | 2022 |
| Safety, tolerability and antitumour activity of LY2780301 (p70S6K/AKT inhibitor) in combination with gemcitabine in molecularly selected patients with advanced or metastatic … E Angevin, PA Cassier, A Italiano, A Gonçalves, A Gazzah, C Terret, ... European Journal of Cancer 83, 194-202, 2017 | 16 | 2017 |
